Antimicrobial susceptibility of viridans group streptococci (Q44899345)

7 December 2017

title

Antimicrobial susceptibility of viridans group streptococci (English)

1 reference

7 December 2017

Tuohy M

1

1 reference

7 December 2017

Washington JA

series ordinal

2

1 reference

7 December 2017

publication date

1 December 1997

1 reference

Diagnostic Microbiology and Infectious Disease

7 December 2017

published in

1 reference

7 December 2017

volume

29

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

277-280

1 reference

Streptococcal and enterococcal bacteremia in patients with cancer.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

Antimicrobial Susceptibilities of Species of Viridans Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

In vitro evaluation of contemporary beta-lactam drugs tested against viridans group and beta-haemolytic streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

Alpha-hemolytic streptococcal bacteremia: a review of 203 episodes during 1980-1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900140-5

7 January 2021

10.1016/S0732-8893(97)00140-5

Identifiers

DOI

1 reference

7 December 2017

1 reference